Here, we performed IHC to investigate the expression of PKM2 protein in a cohort of 70 tissue samples derived from patients with kidney cancer (age, 30–80 years; duplicates per case) and 10 nontumor tissues (age, 14–50 years). The gene discussed is PKM; the disease is kidney cancer.